IAG Wealth Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.7K Buy
1,271
+10
+0.8% +$266 ﹤0.01% 240
2025
Q4
$31.4K Sell
1,261
-646
-34% -$16.3K ﹤0.01% 247
2025
Q3
$48.6K Buy
1,907
+10
+0.5% +$247 0.01% 214
2025
Q2
$46K Sell
1,897
-7,092
-79% -$165K 0.01% 204
2025
Q1
$228K Buy
8,989
+7,695
+595% +$201K 0.04% 103
2024
Q4
$34.3K Buy
1,294
+9
+0.7% +$244 0.01% 222
2024
Q3
$37.2K Sell
1,285
-142
-10% -$4.14K 0.01% 217
2024
Q2
$39.9K Buy
1,427
+8
+0.6% +$220 0.01% 198
2024
Q1
$39.4K Buy
1,419
+8
+0.6% +$222 0.01% 184
2023
Q4
$40.6K Sell
1,411
-23
-2% -$695 0.01% 173
2023
Q3
$47.6K Buy
1,434
+34
+2% +$1.2K 0.01% 154
2023
Q2
$51.4K Sell
1,400
-500
-26% -$19.5K 0.01% 159
2023
Q1
$77.5K Buy
1,900
+500
+36% +$21.6K 0.02% 114
2022
Q4
$71.7K Hold
1,400
0.02% 114
2022
Q3
$61K Buy
1,400
+200
+17% +$9.72K 0.02% 109
2022
Q2
$63K Sell
1,200
-76
-6% -$3.87K 0.02% 110
2022
Q1
$66K Sell
1,276
-31
-2% -$1.61K 0.02% 116
2021
Q4
$77K Buy
1,307
+1,200
+1,121% +$59.5K 0.02% 105
2021
Q3
$5K Buy
107
+75
+234% +$3.32K ﹤0.01% 334
2021
Q2
$2K Sell
32
-630
-95% -$24.5K ﹤0.01% 349
2021
Q1
$24K Buy
662
+332
+101% +$11.8K 0.01% 169
2020
Q4
$13K Buy
+330
New +$12.1K 0.01% 218
2020
Q3
Sell
-22
Closed -$1K 416
2020
Q2
$1K Hold
22
﹤0.01% 402
2020
Q1
$1K Hold
22
﹤0.01% 398
2019
Q4
$1K Buy
+22
New +$784 ﹤0.01% 420

Other funds holding PFE

IAG Wealth Partners's PFE Position: Q1 2026 in Review

IAG Wealth Partners increased its Pfizer (PFE) stake by 0.79% in Q1 2026, buying an estimated $266 and bringing the position to 1,271 shares worth $35.7K. The position accounts for ﹤0.01% of the portfolio, ranked #240.

IAG Wealth Partners first reported a position in PFE in Q4 2019 and has held it in 25 quarters since. The position peaked at $228K in Q1 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • IAG Wealth Partners held 1,271 shares of Pfizer worth $35.7K as of Q1 2026.
  • IAG Wealth Partners bought 10 Pfizer shares in Q1 2026, an estimated $266.
  • Pfizer made up ﹤0.01% of IAG Wealth Partners's portfolio in Q1 2026, its #240 holding.
  • IAG Wealth Partners first reported a position in Pfizer in Q4 2019 and has held it in 25 quarters since.
  • IAG Wealth Partners's Pfizer position peaked at $228K in Q1 2025.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on IAG Wealth Partners's 13F filing for Q1 2026, filed 29 Apr 2026.